SAVA

Cassava Sciences Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

Cassava Sciences is focused on the discovery and development of drugs for the treatment of Alzheimer's disease.

$ 1.73
0.58 %

Cassava Sciences Inc

$ 1.73
0.58 %
SAVA

Cassava Sciences is focused on the discovery and development of drugs for the treatment of Alzheimer's disease.

Price history of Cassava Sciences Inc
Price history of Cassava Sciences Inc

Performance & Momentum

6 Months 44.33 %
1 Year 8.00 %
3 Years 93.28 %
5 Years 96.54 %

Strategic Analysis

Cassava Sciences Inc • 2026

Cassava Sciences is positioned as a speculative biotech focused on Alzheimer’s and, more broadly, neurodegenerative diseases, with an approach combining therapeutic development and diagnostics. Its equity appeal rests primarily on a binary clinical transformation thesis rather than on a diversified or already profitable industrial model.

Strengths
  • Exposure to a huge and structurally underserved medical market, where a credible advance could create significant value
  • Focused positioning in a highly differentiated scientific segment, with an innovation narrative around Alzheimer’s and diagnostics
  • High re-rating potential in the event of clinical or regulatory validation
Weaknesses
  • Very high-risk profile, dependent on the success of still uncertain clinical and regulatory milestones
  • Extremely poor stock-market history, reflecting a strong erosion of investor confidence
  • Lack of sufficiently visible commercial diversification to cushion development setbacks
Momentum

Momentum appears weak and remains consistent with a highly speculative name: the stock is showing a temporary technical rebound, but there is no sign of a strong trend at this stage. Strategically, this points more to a bet on a scientific catalyst than on any durable underlying momentum.

Similar stocks to Cassava Sciences Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone